US 7723111
Activated dual specificity lymphocytes and their methods of use
granted A61KA61K2039/515A61K2239/28
Quick answer
US patent 7723111 (Activated dual specificity lymphocytes and their methods of use) held by The United States of America, as represented by the Department of Health and Human Services expires Mon May 20 2030 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The United States of America, as represented by the Department of Health and Human Services
- Grant date
- Tue May 25 2010 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon May 20 2030 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 15
- CPC classes
- A61K, A61K2039/515, A61K2239/28, A61K2239/31, A61K2239/38